PDF herunterladen
Semin Neurol 2009; 29(2): 111-123
DOI: 10.1055/s-0029-1213732
© Thieme Medical Publishers

Neuro-Ophthalmology of Systemic Disease

Janet C. Rucker1
  • 1Departments of Neurology and Ophthalmology, Mount Sinai Medical Center, New York, New York
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
15. April 2009 (online)

    Lizenzen und Reprints

ABSTRACT

Many neuro-ophthalmologic conditions may result from systemic disease or its treatments. This article provides an update on optic neuropathies, eye movement disorders, and intracranial visual pathway lesions that occur most commonly with systemic disease, are clinical emergencies, or have been identified or clarified in recent publications.

KEYWORDS

Ischemic optic neuropathy - idiopathic intracranial hypertension - paraneoplastic disorders - gaze palsy - metabolic optic neuropathy

REFERENCES

  • 1 The Ischemic Optic Neuropathy Decompression Trial Research Group . Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial.  Arch Ophthalmol. 1996;  114 1366-1374
    PubMedSuche in Google Scholar
  • 2 Beck R W, Servais G E, Hayreh S S. Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis.  Ophthalmology. 1987;  94 1503-1508
    CrossrefPubMedSuche in Google Scholar
  • 3 Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful.  The Ischemic Optic Neuropathy Decompression Trial Research Group . JAMA. 1995;  273 625-632
    CrossrefPubMedSuche in Google Scholar
  • 4 Preechawat P, Bruce B B, Newman N J, Biousse V. Anterior ischemic optic neuropathy in patients younger than 50 years.  Am J Ophthalmol. 2007;  144 953-960
    CrossrefPubMedSuche in Google Scholar
  • 5 Hayreh S S, Joos K M, Podhajsky P A, Long C R. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy.  Am J Ophthalmol. 1994;  118 766-780
    CrossrefPubMedSuche in Google Scholar
  • 6 Hayreh S S, Zimmerman M B. Incipient nonarteritic anterior ischemic optic neuropathy.  Ophthalmology. 2007;  114 1763-1772
    CrossrefPubMedSuche in Google Scholar
  • 7 Patel S V, Holmes J M, Hodge D O, Burke J P. Diabetes and hypertension in isolated sixth nerve palsy: a population-based study.  Ophthalmology. 2005;  112 760-763
    CrossrefPubMedSuche in Google Scholar
  • 8 Jacobson D M. Pupil involvement in patients with diabetes-associated oculomotor nerve palsy.  Arch Ophthalmol. 1998;  116 723-727
    CrossrefPubMedSuche in Google Scholar
  • 9 Chou K L, Galetta S L, Liu G T et al.. Acute ocular motor mononeuropathies: prospective study of the roles of neuroimaging and clinical assessment.  J Neurol Sci. 2004;  219 35-39
    CrossrefPubMedSuche in Google Scholar
  • 10 Goh S Y, Ho S C, Seah L L, Fong K S, Khoo D H. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.  Clin Endocrinol (Oxf). 2004;  60 600-607
    CrossrefPubMedSuche in Google Scholar
  • 11 Eckstein A, Quadbeck B, Mueller G et al.. Impact of smoking on the response to treatment of thyroid associated ophthalmopathy.  Br J Ophthalmol. 2003;  87 773-776
    CrossrefPubMedSuche in Google Scholar
  • 12 Hayreh S S. Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension.  Curr Opin Ophthalmol. 1999;  10 474-482
    CrossrefPubMedSuche in Google Scholar
  • 13 Lee V H, Wijdicks E F, Manno E M, Rabinstein A A. Clinical spectrum of reversible posterior leukoencephalopathy syndrome.  Arch Neurol. 2008;  65 205-210
    CrossrefPubMedSuche in Google Scholar
  • 14 Covarrubias D J, Luetmer P H, Campeau N G. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.  AJNR Am J Neuroradiol. 2002;  23 1038-1048
    PubMedSuche in Google Scholar
  • 15 Jacobson D M. Lyme disease and optic neuritis: long-term follow-up of seropositive patients.  Neurology. 2003;  60 881-882
    PubMedSuche in Google Scholar
  • 16 Bar S, Segal M, Shapira R, Savir H. Neuroretinitis associated with cat scratch disease.  Am J Ophthalmol. 1990;  110 703-705
    PubMedSuche in Google Scholar
  • 17 Schwartz M A, Selhorst J B, Ochs A L et al.. Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple's disease.  Ann Neurol. 1986;  20 677-683
    CrossrefPubMedSuche in Google Scholar
  • 18 Averbuch-Heller L, Paulson G W, Daroff R B, Leigh R J. Whipple's disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording.  J Neurol Neurosurg Psychiatry. 1999;  66 532-535
    CrossrefPubMedSuche in Google Scholar
  • 19 Sadun A A. Metabolic optic neuropathies.  Semin Ophthalmol. 2002;  17 29-32
    CrossrefPubMedSuche in Google Scholar
  • 20 Sadun A A. Mitochondrial optic neuropathies.  J Neurol Neurosurg Psychiatry. 2002;  72 423-425
    PubMedSuche in Google Scholar
  • 21 Zuccoli G, Gallucci M, Capellades J et al.. Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients.  AJNR Am J Neuroradiol. 2007;  28 1328-1331
    CrossrefPubMedSuche in Google Scholar
  • 22 Pittock S J, Kryzer T J, Lennon V A. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.  Ann Neurol. 2004;  56 715-719
    CrossrefPubMedSuche in Google Scholar
  • 23 Cross S A, Salomao D R, Parisi J E et al.. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.  Ann Neurol. 2003;  54 38-50
    CrossrefPubMedSuche in Google Scholar
  • 24 Dalmau J, Graus F, Villarejo A et al.. Clinical analysis of anti-Ma2-associated encephalitis.  Brain. 2004;  127 1831-1844
    CrossrefPubMedSuche in Google Scholar
  • 25 Ko M W, Dalmau J, Galetta S L. Neuro-ophthalmologic manifestations of paraneoplastic syndromes.  J Neuroophthalmol. 2008;  28 58-68
    PubMedSuche in Google Scholar
  • 26 Hayreh S S, Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies.  Ophthalmologica. 2003;  217 239-259
    CrossrefPubMedSuche in Google Scholar
  • 27 Hayreh S S, Podhajsky P A, Zimmerman B. Occult giant cell arteritis: ocular manifestations.  Am J Ophthalmol. 1998;  125 521-526
    CrossrefPubMedSuche in Google Scholar
  • 28 Hayreh S S, Podhajsky P A, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria.  Am J Ophthalmol. 1997;  123 285-296
    CrossrefPubMedSuche in Google Scholar
  • 29 Kupersmith M J, Burde R M, Warren F A, Klingele T G, Frohman L P, Mitnick H. Autoimmune optic neuropathy: evaluation and treatment.  J Neurol Neurosurg Psychiatry. 1988;  51 1381-1386
    CrossrefPubMedSuche in Google Scholar
  • 30 Fechner F P, Faquin W C, Pilch B Z. Wegener's granulomatosis of the orbit: a clinicopathological study of 15 patients.  Laryngoscope. 2002;  112 1945-1950
    CrossrefPubMedSuche in Google Scholar
  • 31 Zoumalan C I, Sadun A A. Optical coherence tomography can monitor reversible nerve-fibre layer changes in a patient with ethambutol-induced optic neuropathy.  Br J Ophthalmol. 2007;  91 839-840
    CrossrefPubMedSuche in Google Scholar
  • 32 Kardon R H, Morrisey M C, Lee A G. Abnormal multifocal electroretinogram (mfERG) in ethambutol toxicity.  Semin Ophthalmol. 2006;  21 215-222
    CrossrefPubMedSuche in Google Scholar
  • 33 Vistamehr S, Walsh T J, Adelman R A. Ethambutol neuroretinopathy.  Semin Ophthalmol. 2007;  22 141-146
    CrossrefPubMedSuche in Google Scholar
  • 34 Rucker J C, Hamilton S R, Bardenstein D, Isada C M, Lee M S. Linezolid-associated toxic optic neuropathy.  Neurology. 2006;  66 595-598
    CrossrefPubMedSuche in Google Scholar
  • 35 Javaheri M, Khurana R N, O'Hearn T M, Lai M M, Sadun A A. Linezolid-induced optic neuropathy: a mitochondrial disorder?.  Br J Ophthalmol. 2007;  91 111-115
    CrossrefPubMedSuche in Google Scholar
  • 36 Egan R, Pomeranz H. Sildenafil (Viagra) associated anterior ischemic optic neuropathy.  Arch Ophthalmol. 2000;  118 291-292
    PubMedSuche in Google Scholar
  • 37 Cunningham A V, Smith K H. Anterior ischemic optic neuropathy associated with Viagra.  J Neuroophthalmol. 2001;  21 22-25
    PubMedSuche in Google Scholar
  • 38 Nagra P K, Foroozan R, Savino P J, Castillo I, Sergott R C. Amiodarone induced optic neuropathy.  Br J Ophthalmol. 2003;  87 420-422
    CrossrefPubMedSuche in Google Scholar
  • 39 Danesh-Meyer H V, Levin L A. Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association?.  Br J Ophthalmol. 2007;  91 1551-1555
    CrossrefPubMedSuche in Google Scholar
  • 40 Mindel J S, Anderson J, Hellkamp A et al.. Absence of bilateral vision loss from amiodarone: a randomized trial.  Am Heart J. 2007;  153 837-842
    CrossrefPubMedSuche in Google Scholar
  • 41 Purvin V, Kawasaki A, Borruat F X. Optic neuropathy in patients using amiodarone.  Arch Ophthalmol. 2006;  124 696-701
    CrossrefPubMedSuche in Google Scholar
  • 42 Shinder R, Frohman L P, Turbin R E. Regression of bilateral optic disc edema after discontinuation of amiodarone.  J Neuroophthalmol. 2006;  26 192-194
    PubMedSuche in Google Scholar
  • 43 Cheng M A, Sigurdson W, Tempelhoff R, Lauryssen C. Visual loss after spine surgery: a survey.  Neurosurgery. 2000;  46 625-630 , discussion 630–621
    CrossrefPubMedSuche in Google Scholar
  • 44 Newman N J. Perioperative visual loss after nonocular surgeries.  Am J Ophthalmol. 2008;  145 604-610
    CrossrefPubMedSuche in Google Scholar
  • 45 Friedman D I. Medication-induced intracranial hypertension in dermatology.  Am J Clin Dermatol. 2005;  6 29-37
    CrossrefPubMedSuche in Google Scholar
  • 46 Solomon D, Ramat S, Tomsak R L et al.. Saccadic palsy after cardiac surgery: characteristics and pathogenesis.  Ann Neurol. 2008;  63 355-365
    CrossrefPubMedSuche in Google Scholar
  • 47 Eggers S D, Moster M L, Cranmer K. Selective saccadic palsy after cardiac surgery.  Neurology. 2008;  70 318-320
    CrossrefPubMedSuche in Google Scholar
  • 48 Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients.  Transplantation. 2000;  69 467-472
    CrossrefPubMedSuche in Google Scholar

Janet C RuckerM.D. 

Associate Professor of Neurology and Ophthalmology, Mount Sinai Medical Center, One Gustave L. Levy Place

Box 1052, New York, NY 10029

eMail: janet.rucker@mssm.edu